{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T16:14:35Z","timestamp":1759421675127,"version":"3.41.0"},"reference-count":23,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2016,9,7]],"date-time":"2016-09-07T00:00:00Z","timestamp":1473206400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD12\/0009\/0017"],"award-info":[{"award-number":["RD12\/0009\/0017"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI14\/00442"],"award-info":[{"award-number":["PI14\/00442"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sanofi-Aventis Spain"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0161727","type":"journal-article","created":{"date-parts":[[2016,9,7]],"date-time":"2016-09-07T17:31:55Z","timestamp":1473269515000},"page":"e0161727","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Cut-Offs and Response Criteria for the Hospital Universitario La Princesa Index (HUPI) and Their Comparison to Widely-Used Indices of Disease Activity in Rheumatoid Arthritis"],"prefix":"10.1371","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9614-5199","authenticated-orcid":true,"given":"Isidoro","family":"Gonz\u00e1lez-\u00c1lvaro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Castrej\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana M.","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Toledano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santos","family":"Casta\u00f1eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Garc\u00eda-Vadillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loreto","family":"Carmona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"EMECAR Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,9,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/annrheumdis-2013-204573","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update","volume":"73","author":"JS Smolen","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"ref2","first-page":"279","article-title":"2014 update of the Consensus Statement of the Spanish Society of Rheumatology on the use of biological therapies in rheumatoid arthritis","volume":"11","author":"R Sanmarti","year":"2015","journal-title":"Reumatol Clin"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1186\/ar2591","article-title":"Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA Study","volume":"11","author":"T Sokka","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1136\/ard.2008.102244","article-title":"Influence of gender on assessments of disease activity and function in early rheumatoid arthritis in relation to radiographic joint damage","volume":"69","author":"M Ahlmen","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.reuma.2009.09.014","article-title":"Influencia del g\u00e9nero en la respuesta al tratamiento en una cohorte de pacientes con artritis reumatoide precoz del \u00e1rea 2 de la Comunidad de Madrid","volume":"6","author":"I Castrej\u00f3n Fern\u00e1ndez","year":"2010","journal-title":"Reumatol Clin"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/acr.21854","article-title":"Development and validation of a new disease activity index as a numerical sum of four variables in patients with early arthritis","volume":"65","author":"I Castrejon","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1136\/ard.2006.054205","article-title":"Comparison of Disease Activity Score (DAS)28- erythrocyte sedimentation rate and DAS28- C-reactive protein threshold values","volume":"66","author":"E Inoue","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"ref8","first-page":"769","article-title":"Are the C-reactive protein values and erythrocyte sedimentation rate equivalent when estimating the 28-joint disease activity score in rheumatoid arthritis?","volume":"26","author":"I Castrejon","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/ard.62.7.667","article-title":"Comparison between women and men with recent onset rheumatoid arthritis of disease activity and functional ability over two years (the TIRA project)","volume":"62","author":"E Hallert","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"ref10","first-page":"2382","article-title":"Disease activity score-28 values differ considerably depending on patient&apos;s pain perception and sex","volume":"34","author":"BF Leeb","year":"2007","journal-title":"J Rheumatol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/1529-0131(199810)41:10<1845::AID-ART17>3.0.CO;2-K","article-title":"Validation of rheumatoid arthritis improvement criteria that include simplified joint counts","volume":"41","author":"AM van Gestel","year":"1998","journal-title":"Arthritis Rheum"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"R138","DOI":"10.1186\/ar2561","article-title":"Trends towards an improved disease state in rheumatoid arthritis over time: influence of new therapies and changes in management approach: analysis of the EMECAR cohort","volume":"10","author":"I Gonzalez-Alvaro","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"FC Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","article-title":"Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis","volume":"38","author":"ML Prevoo","year":"1995","journal-title":"Arthritis Rheum"},{"key":"ref15","first-page":"S100","article-title":"The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis","volume":"23","author":"D Aletaha","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e29492","DOI":"10.1371\/journal.pone.0029492","article-title":"Interleukin 15 levels in serum may predict a severe disease course in patients with early arthritis","volume":"6","author":"I Gonzalez-Alvaro","year":"2011","journal-title":"PLoS One"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/art.1780241012","article-title":"Preliminary criteria for clinical remission in rheumatoid arthritis","volume":"24","author":"RS Pinals","year":"1981","journal-title":"Arthritis Rheum"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.3899\/jrheum.091333","article-title":"Estimated Cutoff Points for the 28-Joint Disease Activity Score Based o,n C-reactive Protein in a Longitudinal Register of Early Arthritis","volume":"37","author":"I Castrejon","year":"2010","journal-title":"J Rheumatol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/art.30129","article-title":"American College of Rheumatology\/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials","volume":"63","author":"DT Felson","year":"2011","journal-title":"Arthritis Rheum"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"ER DeLong","year":"1988","journal-title":"Biometrics"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1136\/ard.2007.079913","article-title":"Influence of age and gender on the 28-joint Disease Activity Score (DAS28) in rheumatoid arthritis","volume":"67","author":"BJ Radovits","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/rheumatology\/keu461","article-title":"Spanish Rheumatology Society and Hospital Pharmacy Society Consensus on recommendations for biologics optimization in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis","volume":"54","author":"I Gonzalez-Alvaro","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"ref23","first-page":"S-33","article-title":"Can remission be maintained with or without further drug therapy in rheumatoid arthritis?","volume":"24","author":"B Saleem","year":"2006","journal-title":"Clin Exp Rheumatol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0161727","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T17:13:02Z","timestamp":1749575582000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0161727"}},"subtitle":[],"editor":[{"given":"Xu-jie","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,9,7]]},"references-count":23,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2016,9,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0161727","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2016,9,7]]}}}